(Q42546419)

2 November 2017

title

Clinical safety and tolerability of losartan (English)

1 reference

2 November 2017

Weber M

1

1 reference

2 November 2017

publication date

1 July 1997

1 reference

2 November 2017

published in

Clinical Therapeutics

1 reference

2 November 2017

volume

19

1 reference

2 November 2017

issue

4

1 reference

2 November 2017

page(s)

604-16; discussion 603

1 reference

The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980086-0

7 January 2021

Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980086-0

7 January 2021

Signal transduction mediated by angiotensin II receptor subtypes expressed in rat renal mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980086-0

7 January 2021

Angiotensin II receptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980086-0

7 January 2021

Efficacy and tolerability of losartan versus enalapril alone or in combination with hydrochlorothiazide in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980086-0

7 January 2021

Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980086-0

7 January 2021

Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980086-0

7 January 2021

Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980086-0

7 January 2021

Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980086-0

7 January 2021

Effects of Losartan on a Background of Hydrochlorothiazide in Patients With Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980086-0

7 January 2021

10.1016/S0149-2918(97)80086-0

Identifiers

DOI

1 reference

2 November 2017

1 reference